HOME >> MEDICINE >> NEWS
Delayed-release stimulant used to treat ADHD may be less subject to abuse

A team led by Massachusetts General Hospital (MGH) researchers has found that a delayed-release stimulant used to treat attention-deficit hyperactivity disorder (ADHD) may be less likely to be abused than other stimulant drugs. Study participants taking therapeutic oral doses of Concerta, a once-daily form of the drug methylphenidate, did not report perceiving and enjoying the drug's subjective effects, features that are associated with a medication's potential for abuse. The report appears in the March 2006 issue of The American Journal of Psychiatry.

"We know that drugs that cause euphoria are potentially abusable, and euphoria requires rapid delivery to the brain. Using sophisticated PET scan imaging, we were able to examine the rate of delivery of both rapid- and delayed-release formulations of methylphenidate and correlate those results with how the drugs felt to study volunteers," says Thomas Spencer, MD, of the MGH Pediatric Psychopharmacology Unit, the paper's lead author. "The ability to show that rate of brain delivery may determine abuse potential is important to our understanding of the safety of different formulations."

Methylphenidate and other stimulant drugs used to treat ADHD act by blocking the dopamine transporter, a molecule on brain cells that takes up the neurotransmitter dopamine, raising its level in the brain. Studies have shown that the brains of ADHD patients have abnormal regulation of dopamine, which plays a key role in the control of movement, behavior and attention. While stimulants are effective for controlling ADHD symptoms, the drugs are also subject to abuse, so the current study was designed to compare the abuse potential of two formulations of methylphenidate.

The researchers compared a traditional, quick-release form of the drug with Concerta, a formulation that is released over 12 hours to produce a gradual increase in blood levels. With Concerta, the drug passes slowly through a hole in capsul
'"/>

Contact: Sue McGreevey
smcgreevey@partners.org
617-724-2764
Massachusetts General Hospital
1-Mar-2006


Page: 1 2

Related medicine news :

1. Investigational nonstimulant Guanfacine XR significantly improved child, adolescent ADHD symptoms
2. Long-term treatment with VYVANSE, first prodrug stimulant, demonstrates significant efficacy in ADHD
3. Study examines risk for misuse of ADHD stimulant medications
4. Spot on treatment for acne
5. Using coxibs and NSAIDs to treat osteoarthritis
6. New treatment boosts muscle function in myasthenia gravis
7. New treatment effective in counteracting cocaine-induced symptoms
8. UCLA researchers awarded $9M contract for study identifiying antibiotic treatment for MRSA
9. Despite claims, not all probiotics can treat diarrhea say experts
10. Preventive treatments in elderly people needs rethinking
11. Osteoporosis screening and treatment may be cost-effective for selected older men

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:3/20/2020)... ... March 21, 2020 , ... ... legal communities together for a day of live discussion and learning online. Experts ... and ethics, telemedicine, whistleblower laws, the role of boards, fraud, waste and abuse, ...
(Date:3/19/2020)... ... March 19, 2020 , ... For weeks, SignatureCare Emergency Center has been ... this week, it announced that while we are still short of some critical safety ... wait for our preparedness measures to be complete. , The Houston, TX based company ...
(Date:3/19/2020)... ... ... As confirmed cases of COVID-19 rapidly increase in the United States, Project ... organization, Project HOPE’s mandate is always to respond where the need is greatest, and ... CEO of Project HOPE. “We will be supporting America’s health workers as they work ...
(Date:3/19/2020)... YORK (PRWEB) , ... March 19, 2020 , ... “We ... and efficient manner,” said Dr. Viral Patel, Founder of Radish Health. “A reliable at ... the care and peace of mind they need in the comfort of their own ...
(Date:3/16/2020)... ... March 16, 2020 , ... The National ... for Coronavirus SARS-CoV-2 (the virus that causes COVID-19 disease) to NKR’s vast network ... and serves approximately 100 transplant programs throughout the United States. NKR has relied ...
Breaking Medicine News(10 mins):
(Date:3/20/2020)... ... March 20, 2020 , ... The economic fallout from ... Many of the most vulnerable community members are those that struggle to pay ... (Asset Limited, Income Constrained, Employed). Today, these ALICE households face an even more ...
(Date:3/19/2020)... ... March 19, 2020 , ... The Pulmonary ... Cleveland Clinic in Cleveland; University of Nebraska Medical Center in ... as PHA Centers of Comprehensive Care (CCC) as part of its Pulmonary Hypertension ...
(Date:3/16/2020)... Fla. (PRWEB) , ... March ... ... a unique, state-of-the-art, integrated, healthcare communication and patient education platform, with content ... and track patient communication, dramatically improving how they support patients before, after, ...
Breaking Medicine Technology:
Cached News: